Direct Diabetes-Related Costs in Young Patients with Early-Onset, Long-Lasting Type 1 Diabetes

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Bächle, Christina ^a   Icks, Andrea ^a,b   Straßburger, Klaus ^a   Flechtner Mors, Marion ^c   Hungele, Andreas ^c   Beyer, Peter ^d   Placzek, Kerstin ^e   Hermann, Ulrich ^f   Schumacher, Andrea ^g   Freff, Markus ^h   Stahl Pehe, Anna ^a   Holl, Reinhard W ^c   Rosenbauer, Joachim ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Department of Orthopedic Surgery   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d Evangelisches Krankenhaus Oberhausen   (Germany)

^e MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^f Pediatric Diabetes Practice   (Germany)

^g KLINIK AM EICHERT   (Germany)

^h Princess Margaret Children's Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CHILD; COHORT ANALYSIS; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE DURATION; DRUG COST; FEMALE; GENDER; GERMANY; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL CARE; HOSPITALIZATION COST; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; MIGRATION; ONSET AGE; OUTPATIENT CARE; PUBERTY; SCHOOL CHILD; SELF MONITORING;

ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GERMANY; HEALTH CARE COSTS; HEALTH SERVICES ACCESSIBILITY; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INSULIN; MALE; RISK FACTORS;

EID: 84881528281     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070567     Document Type: Article

References (47)

1. Tao B, Pietropaolo M, Atkinson M, Schatz D, Taylor D, (2010) Estimating the cost of type 1 diabetes in the U.S.: a propensity score matching method. PLoS One 5 (7):: e11501 doi:10.1371/journal.pone.0011501.
2. Köster I, von Ferber L, Ihle P, Schubert I, Hauner H, (2006) The cost burden of diabetes mellitus: the evidence from Germany-the CoDiM study. Diabetologia 49 (7):: 1498-1504 doi:10.1007/s00125-006-0277-5.
3. Karges B, Neu A, Hofer SE, Rosenbauer J, Kiess W, et al. (2011) (Frequency and influencing factors of ketoacidosis at diabetes onset in children and adolescents - a long-term study between 1995 and 2009). Klin Padiatr 223 (2):: 70-73 doi:10.1055/s-0030-1269884.
4. Neu A, Hofer SE, Karges B, Oeverink R, Rosenbauer J, et al. (2009) Ketoacidosis at diabetes onset is still frequent in children and adolescents: a multicenter analysis of 14,664 patients from 106 institutions. Diabetes Care 32 (9):: 1647-1648 doi:10.2337/dc09-0553.
5. Dabelea D, (2009) The accelerating epidemic of childhood diabetes. Lancet 373 (9680):: 1999-2000 doi:10.1016/S0140-6736(09)60874-6.
6. von Ferber L, Köster I, Hauner H, (2007) Medical costs of diabetic complications total costs and excess costs by age and type of treatment results of the German CoDiM Study. Exp Clin Endocrinol Diabetes 115 (2):: 97-104 doi:10.1055/s-2007-949152.
7. Köster I, Hauner H, von Ferber L, (2006) Heterogeneity of costs of diabetic patients: the Cost of Diabetes Mellitus Study. Dtsch Med Wochenschr 131 (15):: 804-810 doi:10.1055/s-2006-939850.
8. Bächle CC, Holl RW, Strassburger K, Molz E, Chernyak N, et al. (2012) Costs of paediatric diabetes care in Germany: current situation and comparison to the year 2000. Diabet Med 29: 1327-1334 doi:10.1111/j.1464-5491.2012.03645.x.
9. Ying AK, Lairson DR, Giardino AP, Bondy ML, Zaheer I, et al. (2011) Predictors of direct costs of diabetes care in pediatric patients with type 1 diabetes. Pediatr Diabetes 12: 177-182 doi:10.1111/j.1399-5448.2010.00680.x.
10. Wiréhn A, Andersson A, Ostgren CJ, Carstensen J, (2008) Age-specific direct healthcare costs attributable to diabetes in a Swedish population: a register-based analysis. Diabet Med 25 (6):: 732-737 doi:10.1111/j.1464-5491.2008.02444.x.
11. Zhang P, Imai K, (2007) The relationship between age and healthcare expenditure among persons with diabetes mellitus. Expert Opin Pharmacother 8 (1):: 49-57 doi:10.1517/14656566.8.1.49.
12. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G, (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 373 (9680):: 2027-2033 doi:10.1016/S0140-6736(09)60568-7.
13. Tao BT, Taylor DG, (2010) Economics of type 1 diabetes. Endocrinol Metab Clin North Am 39 (3):: 499-512 doi:10.1016/j.ecl.2010.05.004.
14. Rosenbauer J, Stahl A, (2010) Häufigkeit des Diabetes mellitus im Kindes- und Jugendalter in Deutschland. Der Diabetologe 10 (6):: 177-189.
15. Soltesz G, Patterson C, Dahlquist G (2009) Diabetes in the Young: a Global Perspective. IDF Diabetes Atlas. Brussels: International Diabetes Federation.
16. Rosenbauer J, Herzig P, von Kries R, Neu A, Giani G, (1999) Temporal, seasonal, and geographical incidence patterns of type I diabetes mellitus in children under 5 years of age in Germany. Diabetologia 42 (9):: 1055-1059 doi:10.1007/s001250051270.
17. Hammes HP, Kerner W, Hofer S, Kordonouri O, Raile K, et al. (2011) Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8,784 patients. Diabetologia 54 (8):: 1977-1984 doi:10.1007/s00125-011-2198-1.
18. Rosenbauer J, Dost A, Karges B, Hungele A, Stahl A, et al. (2012) Improved Metabolic Control in Children and Adolescents With Type 1 Diabetes: A trend analysis using prospective multicenter data from Germany and Austria. Diabetes Care 35 (1):: 80-86 doi:10.2337/dc11-0993.
19. Grulich-Henn J, Wagner V, Thon A, Schober E, Marg W, et al. (2010) Entities and frequency of neonatal diabetes: data from the diabetes documentation and quality management system (DPV). Diabet Med 27 (6):: 709-712 doi:10.1111/j.1464-5491.2010.02965.x.
20. Dost A, Klinkert C, Kapellen T, Lemmer A, Naeke A, et al. (2008) Arterial hypertension determined by ambulatory blood pressure profiles: contribution to microalbuminuria risk in a multicenter investigation in 2,105 children and adolescents with type 1 diabetes. Diabetes Care 31 (4):: 720-725 doi:10.2337/dc07-0824.
21. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329 (14):: 977-986 doi:10.1056/NEJM199309303291401.
22. Kilpatrick ES, Rumley AG, Dominiczak MH, Small M, (1994) Glycated haemoglobin values: problems in assessing blood glucose control in diabetes mellitus. BMJ 309 (6960):: 983-986 doi:10.1136/bmj.309.6960.983.
23. Marshall SM, Barth JH, (2000) Standardization of HbA1c measurements: a consensus statement. Ann Clin Biochem 37 (Pt 1):: 45-46.
24. Gerstl E, Rabl W, Rosenbauer J, Gröbe H, Hofer SE, et al. (2008) Metabolic control as reflected by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decade. Eur J Pediatr 167 (4):: 447-453 doi:10.1007/s00431-007-0586-9.
25. Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P, et al. (2009) Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 10 Suppl 12: 71-81 doi:10.1111/j.1399-5448.2009.00582.x.
26. Ballesta M, Carral F, Olveira G, Girón JA, Aguilar M, (2005) Costes económicos asociados a la diabetes tipo 1. Rev Clin Esp (Revista Clínica Española) 205 (11):: 523-527.
27. Govan L, Wu O, Briggs A, Colhoun HM, McKnight JA, et al. (2011) Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 54 (8):: 2000-2008 doi:10.1007/s00125-011-2176-7.
28. Icks A, Rosenbauer J, Haastert B, Rathmann W, Grabert M, et al. (2004) Direct costs of pediatric diabetes care in Germany and their predictors. Exp Clin Endocrinol Diabetes 112 (6):: 302-309 doi:10.1055/s-2004-820909.
29. Busch K (2007) GKV-Versicherte nach Alter und Wohnort. GKV-Statistik KM6 zum 1. Juli 2007. Berlin. Available: http://www.bmg.bund.de/fileadmin/redaktion/pdf_statistiken/krankenversicherung/2007-km6-pdf.pdf. Accessed 2013 Apr 15.
30. Thompson SG, (2000) How should cost data in pragmatic randomised trials be analysed. BMJ 320 (7243):: 1197-1200.
31. Mihaylova B, Briggs A, O'Hagan A, Thompson SG, (2011) Review of statistical methods for analysing healthcare resources and costs. Health Econ 20 (8):: 897-916 doi:10.1002/hec.1653.
32. Duan N, Manning WG, Morris CN, Newhouse JP, (1983) A comparison of alternative models for the demand for medical care. J Bus Econ Stat (Journal of Business & Economic Statistics) 1 (2):: 115-126.
33. McNutt L, Wu C, Xue X, Hafner JP, (2003) Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157 (10):: 940-943.
34. Chodick G, Heymann AD, Wood F, Kokia E, (2005) The direct medical cost of diabetes in Israel. Eur J Health Econ 6 (2):: 166-171 doi:10.1007/s10198-004-0269-7.
35. Petitti D, Klingensmith GJ, Bell RA, Andrews JS, Dabelea D, et al. (2009) Glycemic control in youth with diabetes: The SEARCH for Diabetes in the Youth Study. J Pediatr 155: 668-672 doi:10.1016/j.jpeds.2009.05.025.
36. DeBeaufort C, Swift P, Skinner TC, Aanstoot HJ, Aman J, et al. (2007) Continuing stability of center differences in pediatric diabetes care: Do advances in diabetes treatment improve outcome? The Hvidoere study group on childhood diabetes 30 (2245-2250). doi:10.2337/dc07-0475.
37. Krishnan S, Fields D, Kenneth C, (2012) Sex differences in cardiovascular disease risk in adolescents with type 1 diabetes. Gender Medicine 9 (4):: 251-258 Available: http://dx.doi.org/10.1016/j.genm.2012.05.003.
38. Schwab KO, Doerfer J, Hecker W, Grulich-Henn J, Wiemann D, et al. (2006) Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV). Diabetes Care 29 (2):: 218-225.
39. Kamtsiuris P, Bergmann E, Rattay P, Schlaud M, (2007) Inanspruchnahme medizinischer Leistungen. Ergebnisse des Kinder- und Jugendgesundheitssurveys (KiGGS). Bundesgesundheitsbl 50 (836-850).
40. Ziegler R, Heidtmann B, Hilgard D, Hofer S, Rosenbauer J, et al. (2011) Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. Pediatr Diabetes 12 (1):: 11-17 doi:10.1111/j.1399-5448.2010.00650.x.
41. Raile K, Galler A, Hofer S, Herbst A, Dunstheimer D, et al. (2007) Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 30 (10):: 2523-2528 doi:10.2337/dc07-0282.
42. Molitch ME, Steffes M, Sun W, Rutledge B, Cleary P, et al. (2010) Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care 33 (7):: 1536-1543 doi:10.2337/dc09-1098.
43. Boer IH de, Rue TC, Cleary PA, Lachin JM, Molitch ME, et al. (2011) Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med 171 (5):: 412-420 doi:10.1001/archinternmed.2011.16.
44. Nishimura R, Dorman JS, Bosnyak Z, Tajima N, Becker DJ, et al. (2003) Incidence of ESRD and survival after renal replacement therapy in patients with type 1 diabetes: a report from the Allegheny County Registry. Am J Kidney Dis 42 (1):: 117-124 doi:10.1016/S0272-6386(03)00414-1.
45. Johnson JA, Pohar SL, Majumdar SR, (2006) Health care use and costs in the decade after identification of type 1 and type 2 diabetes: a population-based study. Diabetes Care 29 (11):: 2403-2408 doi:10.2337/dc06-0735.
46. Jonsson PM, Marké LA, Nyström L, Wall S, Ostman J, (2000) Excess costs of medical care 1 and 8 years after diagnosis of diabetes: estimates from young and middle-aged incidence cohorts in Sweden. Diabetes Research and Clinical Practice 50 (1):: 35-47.
47. Colagiuri S, Brnabic A, Gomez M, Fitzgerald B, Buckley A, et al. (2009) DiabCo$t Australia Type 1: Assessing the burden of Type 1 Diabetes in Australia. Diabetes Australia, Canberra. November, 2009.